PH22478A - Substituted alkyl pyridinium or pyridimium salts and pharmaceutical preparation thereof - Google Patents

Substituted alkyl pyridinium or pyridimium salts and pharmaceutical preparation thereof

Info

Publication number
PH22478A
PH22478A PH33289A PH33289A PH22478A PH 22478 A PH22478 A PH 22478A PH 33289 A PH33289 A PH 33289A PH 33289 A PH33289 A PH 33289A PH 22478 A PH22478 A PH 22478A
Authority
PH
Philippines
Prior art keywords
pyridimium
salts
substituted alkyl
pharmaceutical preparation
alkyl pyridinium
Prior art date
Application number
PH33289A
Other languages
English (en)
Inventor
Cassal Dr Jean-Marie
Edenhofer Dr Albrecht
Ramuz Dr Henri
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH22478A publication Critical patent/PH22478A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH33289A 1985-01-16 1986-01-15 Substituted alkyl pyridinium or pyridimium salts and pharmaceutical preparation thereof PH22478A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH18785 1985-01-16

Publications (1)

Publication Number Publication Date
PH22478A true PH22478A (en) 1988-09-12

Family

ID=4181245

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33289A PH22478A (en) 1985-01-16 1986-01-15 Substituted alkyl pyridinium or pyridimium salts and pharmaceutical preparation thereof

Country Status (16)

Country Link
US (2) US4692450A (fr)
EP (1) EP0189094A3 (fr)
JP (1) JPS61167658A (fr)
CN (1) CN86100228A (fr)
AU (1) AU5220986A (fr)
DK (1) DK19186A (fr)
ES (1) ES8800183A1 (fr)
FI (1) FI860180A7 (fr)
GR (1) GR860082B (fr)
HU (1) HU196181B (fr)
IL (1) IL77565A (fr)
MC (1) MC1729A1 (fr)
NO (1) NO860099L (fr)
PH (1) PH22478A (fr)
PT (1) PT81842B (fr)
ZA (1) ZA86171B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8603971A1 (es) * 1984-05-28 1986-01-01 Vyzk Ustav Textil Zuslechtovan Un metodo para el apresto y el lavado de tintes y-o estampa-dos en materiales textiles que contienen fibras de celulosa
DE3823991A1 (de) * 1988-07-15 1990-02-15 Basf Ag Heterocyclisch substituierte (alpha)-aryl-acrylsaeureester und fungizide, die diese verbindungen enthalten
US5194438A (en) * 1988-07-15 1993-03-16 Basf Aktiengesellschaft α-arylacrylates substituted by a trifluoromethylpyrimidinyloxy radical, fungicidal compositions and methods
EP0366189A3 (fr) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Lactames-quinolones antimicrobiennes
US5077409A (en) * 1990-05-04 1991-12-31 American Cyanamid Company Method of preparing bis-aryl amide and urea antagonists of platelet activating factor
US5128351A (en) * 1990-05-04 1992-07-07 American Cyanamid Company Bis-aryl amide and urea antagonists of platelet activating factor
US5231182A (en) * 1990-05-04 1993-07-27 American Cyanamid Company Method of making certain aryl containing amides
US5225425A (en) * 1990-05-04 1993-07-06 American Cyanamid Company Bis-aryl amide antagonists of platelet activating factor
US6121300A (en) 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
US6417322B1 (en) 2000-09-25 2002-07-09 Essilor International Compagnie General D'optique Episulfide based polymerizable composition catalyzed by an (alkoxyphenyl)phosphine, articles made therefrom and process for making same
US6592801B2 (en) 2001-04-30 2003-07-15 Essilor International Compagnie Generale D'optique Photopolymerization of episulfides using metal complexes and its use for making ophthalmic lenses
TW200900072A (en) * 2007-03-22 2009-01-01 Arete Therapeutics Inc Soluble epoxide hydrolase inhibitors

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB704014A (en) * 1951-02-10 1954-02-17 Hendrik Jan Petry Improvements in and relating to quaternary ammonium derivatives of 1:2-dihydroxy-3-aminopropane
FR1271014A (fr) * 1958-06-05 1961-09-08 Spofa Vereinigte Pharma Werke Procédé de préparation de sels de pyridine nouveaux
NL282004A (fr) * 1961-08-25
US3316272A (en) * 1962-06-27 1967-04-25 Richardson Merrell Inc Heterocyclic derivatives of triphenyl-ethylenes, triphenylethanes and triphenylethanols
US3374232A (en) * 1964-03-11 1968-03-19 Ciba Geigy Corp N-aryl pyrimidinium compounds
GB1345872A (en) * 1970-09-03 1974-02-06 Wyeth John & Brother Ltd Amino-and acylamino-pyridine and hydropyridine derivatives
GB1404868A (en) * 1972-12-21 1975-09-03 Wyeth John & Brother Ltd Pyridine tetrahydropyridine and piperidine derivatives
LU65114A1 (fr) * 1971-04-26 1972-07-12
US3997519A (en) * 1972-05-15 1976-12-14 Gaf Corporation Method of producing quaternary pyridinium compounds
US3825549A (en) * 1972-10-24 1974-07-23 Squibb & Sons Inc Certain dihydropyrido(2,1-b)(1,3)benzodi-azepines and benzodiazocines
US4175196A (en) * 1973-11-15 1979-11-20 The Dow Chemical Company Certain pyridinium surfactants
GB1528576A (en) * 1974-11-04 1978-10-11 Alcan Res & Dev Lubricants for cold working of aluminium
JPS5169360A (en) * 1974-12-05 1976-06-15 New Nippon Electric Co Handotaisoshino seizohoho
US4172893A (en) * 1975-12-19 1979-10-30 Rohm And Haas Company Rodenticidal 3-pyridylmethyl phenyl carbamate metal salt complexes
DE2623228C3 (de) * 1976-05-24 1981-09-10 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren N-Acyl-substituierte Benzamide, Verfahren zu ihrer Herstellung und Arzneimittel, enthaltend solche Benzamide
DE2639701A1 (de) * 1976-09-03 1978-03-09 Degussa Verfahren zur herstellung substituierter pyridine
US4134982A (en) * 1977-09-26 1979-01-16 Warner-Lambert Company Antipsychotic 1-[4,4-Bis(4-fluorophenyl) butyl]-4-phenoxy-1,2,3,6-tetrahydropyridines
GB2023134B (en) * 1978-04-28 1983-02-23 Asahi Chemical Ind Molecular aggregate having an ordered structure
GB2038816B (en) * 1978-11-30 1982-10-27 Wyeth John & Brother Ltd Dithio pyridinium compounds
GB2039218B (en) * 1978-11-30 1983-07-27 Wyeth John & Brother Ltd Pharmaceutical compositions
GB2038825B (en) * 1978-12-16 1983-02-09 Wyeth John & Brother Ltd Heterocyclic compounds substituted by heterocyclyl-alkyl-thio groups
US4301044A (en) * 1980-01-22 1981-11-17 The Procter & Gamble Company Biodegradable zwitterionic surfactant compounds
JPS57108277A (en) * 1980-12-26 1982-07-06 Asahi Chem Ind Co Ltd Production of 4-butanolides
JPS57108276A (en) * 1980-12-26 1982-07-06 Asahi Chem Ind Co Ltd Manufacture of 4-butanolides
US4376767A (en) * 1981-01-02 1983-03-15 Merck & Co., Inc. Pyridylmethyl esters of selected bio-affecting carboxylic acids
JPS6145273A (ja) * 1984-08-10 1986-03-05 富士通機電株式会社 流動表示装置

Also Published As

Publication number Publication date
ES8800183A1 (es) 1987-10-16
ES550889A0 (es) 1987-10-16
DK19186A (da) 1986-07-17
FI860180A0 (fi) 1986-01-15
US4692450A (en) 1987-09-08
ZA86171B (en) 1986-08-27
PT81842A (en) 1986-02-01
EP0189094A3 (fr) 1987-09-23
US4675328A (en) 1987-06-23
NO860099L (no) 1986-07-17
HUT40417A (en) 1986-12-28
EP0189094A2 (fr) 1986-07-30
JPS61167658A (ja) 1986-07-29
CN86100228A (zh) 1986-10-29
IL77565A (en) 1988-12-30
DK19186D0 (da) 1986-01-15
AU5220986A (en) 1986-07-24
FI860180A7 (fi) 1986-07-17
MC1729A1 (fr) 1986-12-15
GR860082B (en) 1986-05-14
PT81842B (en) 1987-11-20
HU196181B (en) 1988-10-28

Similar Documents

Publication Publication Date Title
PH24739A (en) New drug preparation
NZ217931A (en) Pyridone derivatives and pharmaceutical compositions
DK546886D0 (da) Farmaceutisk praeparat
EP0193415A3 (en) Spiro-3-heteroazolidine compounds and salts thereof, their preparation and pharmaceutical agents thereof
US4714706B1 (en) Pyridyloxy derivatives and their use as insecticides
PH22478A (en) Substituted alkyl pyridinium or pyridimium salts and pharmaceutical preparation thereof
NZ217342A (en) 4-amino-n-(alkyl n -p-benzamide derivatives and pharmaceutical compositions
GB2189239B (en) Furosemide salts
GB8607817D0 (en) Drug preparation
GR862211B (en) Azolyl-cyclopropyl-ethanol derivatives methods for their preparation and their use
GB2170196B (en) Bisimidazolium salts
GB8500310D0 (en) Pharmaceutical preparation
PH24135A (en) Quinoline derivatives and pharmaceutical composition containing said compounds
DE3665171D1 (en) Radical-ion salts
GR860058B (en) Method for the preparation of basic thioether and its salt
IL79796A0 (en) Hydropyridine derivatives
DE3564574D1 (en) Pyridinium salts and fungicides and bactericides containing them
DK465786D0 (da) Phenoxyforbindelser samt deres fremstilling og anvendelse
NZ215580A (en) Enteral non-adjuvenated monobacterial vaccines
DK52186D0 (da) Farmaceutisk praeparat indeholdende indolderivater
GB2188046B (en) Hydroxymethylcephem compounds and their preparation
MY8600650A (en) New phenoxypropanolamine salts and pharmaceutical preparation thereof
GB8608836D0 (en) Salt
ZA866442B (en) Hydropyridine derivatives
GB8522761D0 (en) Pharmaceutical preparation